Article

FDA approves 1-bottle RGP lens cleaner

The first one-bottle daily lens-care system for rigid gas permeable (RGP) contact lenses will be available this month from Bausch & Lomb. The FDA approved Boston Simplus Multi-Action Solution in May.

Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Related Content
Formosa Pharmaceuticals announces top-line results from Chinese trial evaluating APP13007
November 6th 2024

Formosa Pharmaceuticals announces top-line results from Chinese trial evaluating APP13007

Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures
March 29th 2024

(EyePod) From idea to impact: Navigating ophthalmic innovation

Raising cataract surgery procedure to an art and an experience
October 21st 2024

Raising cataract surgery procedure to an art and an experience

EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
December 19th 2023

EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

Harrow relaunches triamcinolone acetonide injectable suspension
October 3rd 2024

Harrow relaunches triamcinolone acetonide injectable suspension

Eyenovia announces commercial availability of clobetasol propionate ophthalmic suspension 0.05% in US
September 30th 2024

Eyenovia announces commercial availability of clobetasol propionate ophthalmic suspension 0.05% in US

© 2024 MJH Life Sciences

All rights reserved.